Enterprise software company Veeva has become an indispensable nucleus for the life sciences industry, helping Big Pharma manage customer databases, track drug developments, and organize clinical trials. Revenues rose by 33% last year to $544 million, as the likes of Abbott, Merck, and Pfizer employed a suite of its cloud-based offerings. Vault, its new content management system, is already being used by 35 of the top 50 pharma companies. The platform could help Veeva take a bigger chunk of the global life sciences applications market, forecast to reach $6.8 billion in sales by 2020.
Peter P. Gassner
|Revenues ($M) (Past 12 Months)||$617|
|Profits ($M) (Past 12 Months)||$117|
|Market Value as of Oct. 9, 2017 ($M)||$8,170|